MDXXF (Pharmala Biotech Holdings) Change In Inventory: $-0.16 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDXXF Pharmala Biotech Holdings Inc MDXXF
33 GF Score
Price $0.17
GF Value $0.17
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Pharmala Biotech Holdings Change In Inventory?

Pharmala Biotech Holdings MDXXF +1.38% 33 Change In Inventory is $-0.16 Mil as of May. 2026. GuruFocus rates MDXXF with a GF Score™ of 33/100 and a GF Value™ of $0.17 (Fairly Valued). The stock has 2 warning signs investors should review.

Pharmala Biotech Holdings's change in inventory for the quarter that ended in May. 2026 was $-0.16 Mil. It means Pharmala Biotech Holdings's inventory increased by $0.16 Mil from Feb. 2026 to May. 2026 .

Pharmala Biotech Holdings's change in inventory for the fiscal year that ended in Aug. 2025 was $-0.01 Mil. It means Pharmala Biotech Holdings's inventory increased by $0.01 Mil from Aug. 2024 to Aug. 2025 .

Pharmala Biotech Holdings's Total Inventories for the quarter that ended in May. 2026 was $0.44 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Pharmala Biotech Holdings's Days Inventory for the quarter that ended in May. 2026 was 259.38.

Inventory Turnover measures how fast the company turns over its inventory within a year. Pharmala Biotech Holdings's Inventory Turnover for the quarter that ended in May. 2026 was 0.35.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pharmala Biotech Holdings's Inventory-to-Revenue for the quarter that ended in May. 2026 was 0.97.

Pharmala Biotech Holdings  (OTCPK:MDXXF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pharmala Biotech Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.361/0.127*365 / 4
=259.38

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pharmala Biotech Holdings's Inventory Turnover for the quarter that ended in May. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.127 / 0.361
=0.35

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharmala Biotech Holdings's Inventory to Revenue for the quarter that ended in May. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.361 / 0.374
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings Change In Inventory Related Terms

Pharmala Biotech Holdings Change In Inventory Historical Data

* Premium members only.

The historical data trend for Pharmala Biotech Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings Change In Inventory Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Change In Inventory
0.00 -0.09 -0.00 -0.17 -0.01

Pharmala Biotech Holdings Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 0.01 0.01 -0.02 -0.16
MDXXF
33GF Score
Pharmala Biotech Holdings Inc MDXXF
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmala Biotech Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-0.16 Mil mean?
Pharmala Biotech Holdings (MDXXF) has a Change In Inventory of $-0.16 Mil as of May. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Pharmala Biotech Holdings and its competitors.
Is Pharmala Biotech Holdings' Change In Inventory too high?
Pharmala Biotech Holdings' current Change In Inventory is $-0.16 Mil. Overall, Pharmala Biotech Holdings has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharmala Biotech Holdings' Change In Inventory compare to VRTX and REGN?
Pharmala Biotech Holdings' Change In Inventory of $-0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Pharmala Biotech Holdings and its competitors. Pharmala Biotech Holdings's current Change In Inventory is $-0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmala Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmala Biotech Holdings (MDXXF) is currently considered Fairly Valued. The stock's GF Value™ is $0.17, compared to a current price of $0.17 — trading 0.8% below its estimated fair value. The current Change In Inventory is $-0.16 Mil. Pharmala Biotech Holdings' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Pharmala Biotech Holdings (MDXXF), the current Change In Inventory is $-0.16 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmala Biotech Holdings (MDXXF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmala Biotech Holdings stock appears to be undervalued. The current stock price of $0.17 is trading 0.8% below its estimated GF Value™ of $0.17. GuruFocus considers Pharmala Biotech Holdings to be Fairly Valued.

Key valuation signals for MDXXF:

  • Change In Inventory: $-0.16 Mil
  • GF Value™: $0.17 vs. price of $0.17 (0.8% below fair value)
  • GF Score™: 33/100 with 2 warning signs

No single metric tells the full story. See the MDXXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmala Biotech Holdings Business Description

Other Exchanges MDMA:Canada
Address 1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9
Pharmala Biotech Holdings Inc is a Canadian Biotechnology company focused on the development, manufacture and sales of MDMA and MDXX class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The company produces its MDMA active pharmaceutical ingredient under the LaNeo brand through Good Manufacturing Practice (GMP) processes, aiming to address shortages for clinical trials investigating treatments for various disorders. It generates revenue from the sale of tablets, raw MDMA and MDXX compounds/formulations, and royalties from licensing of its IP.
33GF Score

Get the complete analysis for MDXXF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price
$0.17
GF Value